A professor at Tel Aviv University (TAU) has been granted a patent by the United States Patent and Trademark Office (USPTO) for his innovative vaccine design for the novel coronavirus, also known as SARS-CoV-2, TAU announced on Sunday.
Prof. Jonathan Gershoni of the School of Molecular Cell Biology and Biotechnology at TAU’s George S. Wise…
An American patient diagnosed with the coronavirus (COVID-19) has been given a treatment by Israeli-based Pluristem that, so far, has a 100 percent survival rate.
The development, which occurred under the Israel’s compassionate-use program, comes days after the company released preliminary data showing that six critically ill coronavirus patients…
The first two patients who were treated with a new Israeli treatment for the novel COVID-19 after testing positive have shown significant improvement, with one of them even being removed from the intensive care unit (ICU) within days of treatment.
Israeli biopharmaceutical RedHill Biopharma Ltd. administered their experimental drug, Opaganib, in…
The Hebrew University of Jerusalem has received a $4.2 million donation from the Edmond de Rothschild Foundation to fund coronavirus research.
The money will be used to fund 60 Hebrew University research teams that are “working to find a vaccine, produce faster and cheaper testing methods, and develop targeted treatments for those afflicted by…
Researchers at the Hebrew University of Jerusalem announced on Sunday that they have developed a new method of testing for COVID-19 which is not only 4-10 times faster than the tests most commonly used today, but also significantly cheaper, while supplying the same level of accuracy.
Moreover, most of the materials required to perform the new…
Six critically ill coronavirus patients in Israel who are considered high-risk for mortality have been treated with Pluristem’s placenta-based cell-therapy product and survived, according to preliminary data provided by the Haifa-based company.
The patients were treated at three different Israeli medical centers for one week under the country’s…
With the Israeli health system under massive pressure due to the coronavirus pandemic, some 2,000 medical students are volunteering to help in the relief efforts, working long hours without pay and risking infection themselves.
The Israeli news site N12 quoted one of the students, identified only as “A.,” as saying, “We didn’t think about money…
An Israeli biopharmaceutical firm has treated a coronavirus patient with an experimental drug aimed to lessen symptoms, after receiving a green light to use the drug in Italy.
According to Redhill Biopharma, a coronavirus patient currently suffering from respiratory complaints in hospital in Israel was dosed with the drug following approval from…
Israeli researchers said they are days away from finishing production of the active component of a coronavirus vaccine that could be tested on humans starting June 1.
“We are in the final stages and within a few days we will hold the proteins—the active component of the vaccine,” Dr. Chen Katz, group leader of the biotechnology group at the MIGAL…
A team of Israeli researchers says that they are days away from completing the production of the active component of a coronavirus vaccine that could be tested on humans as early as June 1.
“We are in the final stages and within a few days we will hold the proteins – the active component of the vaccine,” Dr. Chen Katz, group leader of MIGAL’s…
The Israel Innovation Authority (IIA) will inject NIS 650 million (approx. $180m.) into the Israeli hi-tech sector, including funds dedicated to researchers combating the coronavirus, after the Finance Ministry released funds frozen since the start of the year.
A total of NIS 600m. ($165m.) will be transferred to companies that have applied for…
Three professors from the Hebrew University have collectively been awarded over 7 million euros in funding to pursue “ground breaking and high risk projects” by the European Research Council (ERC).
“The ERC Advanced Grants fund outstanding researchers throughout Europe. Their pioneering work has the potential to make a difference in people’s…
The Israel Institute for Biological Research (IIBR) has begun testing a COVID-19 vaccine prototype on rodents at its bio-chemical defense laboratory, a source told Reuters on Tuesday.Prime Minister Benjamin Netanyahu ordered the IIBR, in rural Ness Ziona, to join the fight against the coronavirus pandemic on Feb. 1, prompting an easing of its…
NeuroRx, a US-Israeli pharmaceutical company, and Relief Therapeutics, a Swiss drug development company, announced Sunday they received the go-ahead from the Food and Drug Administration (FDA) for phase two trials of a drug that could take on a deadly condition associated with COVID-19.
The companies revealed that the FDA issued a “study may…
A New York rabbi who recovered from a mild case of COVID-19 donated blood plasma to researchers on Friday in the hope that his antibodies could be used to treat patients with more severe coronavirus symptoms.
Rabbi Daniel Nevins, dean of the rabbinical school at the Jewish Theological Seminary in New York, was laid up for a few days earlier this…
Microsoft’s research and development center in Israel, in collaboration with Israel’s emergency service Magen David Adom (MADA), the Tel Aviv Sourasky Medical Center (Ichilov Hospital), and the Israeli Air Force, is working to develop a low-cost ventilator that can be mass-produced in labs without the need of dedicated factories, Microsoft Israel…
Israeli scientist and entrepreneur Prof. Avi Schroeder is working on a preventative drug for the coronavirus by adapting a food additive designed for shrimp.The project is one of the several emergency projects that are the focus of around-the-clock work by 20 different labs at the Technion Institute of Technology to work on coronavirus vaccines,…
Can coronavirus carriers be identified by analyzing their voice?
That’s what an Israeli startup is trying to find out, in collaboration with the Defense Ministry’s Administration for the Development of Weapons and Technological Infrastructure.
The startup, Vocalis Health, is currently conducting research aiming to identify a vocal fingerprint…